Resource Library
See how top researchers are using our technology to predict durable responses and unlock pre-clinical meaning.
Opto® Memory B Discovery Camelid: Discover Heavy Chain Antibodies (HCAbs) with Single B Cell Screening
Opto® Memory B Discovery Camelid: Discover Heavy Chain Antibodies (HCAbs) with Single B Cell Screening
Harnessing the Beacon Optofluidic Platform for Streamlined Discovery of Internalizing Antibodies
Enabling iPSC Cell Line Development Using Bruker’s Optofluidic Systems
Bring Product Quality Assessment into Early Clone Selection with the Opto® Assure Aggregation Assay
Catalent Biologics on Cell Line Development
Increase CDMO Revenue with the Opto Cell Line Development Workflow
Automated Cell Line Development on the Beacon® Platform
FDA-Accepted Monoclonality Assurance on the Beacon® Optofluidic System for Cell Line Development
Opto® B Discovery: Relative Affinity Ranking for Soluble Antigens
Going Beyond Simple Antibody Hit Generation in Opto® B Discovery with Relative Affinity Ranking for Soluble Antigens
Enabling Analysis of Single Mesenchymal Stem Cells Using Bruker’s Optofluidic Systems
SpotLight™ Reagents to Expedite Productivity and Quality Screening in Cell Line Development Workflows
Unveiling Critical Translational Biomarkers through Single-Cell Analysis
Validating the Functional Performance of Immune Cells at a Single-Cell Level
Accelerating CAR and TCR Discovery with Single-Cell Functional Screening
Accelerating Functional Antibody Therapeutics Development with Bruker’s Beacon® Optofluidic System
Relative Affinity Ranking of Recombinant Antigen-Specific Antibody Hits with Bruker’s Beacon® Optofluidic System
Revolutionizing Adoptive Cell Therapy Development with Bruker’s Beacon® Platform
T Cell Data Analysis Export File
Opto® Memory B Discovery Enables Multispecies Screening Capabilities